State Action
MInnesota - Oppose SF 1098
CCAGW urges Minnesota senators to oppose SF 1098, the Prescription Drug Price Transparency Act.
Washington - Oppose SB 6088
CCAGW urges Washington State senators to oppose SB 6088, Establishing a Prescription Drug Affordability Board Act.
Colorado - Oppose SB20-119
CCAGW urges Colorado State senators to oppose SB20-119, which would expand international drug importation beyond Canada.
Michigan - Oppose SB 596, SB 597, SB 598
CCAGW urges Michigan State senators to oppose legislation that would impose more restrictive requirements to the detriment of the state’s energy market.
New Mexico - Oppose SB 1 (House)
CCAGW urges New Mexico State Representatives to oppose SB 1, the Wholesale Prescription Drug Importation Act.
New Mexico - Oppose SB 1 (Senate)
CCAGW urges New Mexico State Senators to oppose SB 1, the Wholesale Prescription Drug Importation Act.
Oregon - CCAGW Urges Opposition to Drug Importation Legislation
CCAGW urges Oregon State Legislators to oppose the reintroduction of, or any new, price-control drug importation legislation.
Washington - Oppose SB 6088 and SB 6110
CCAGW urges Washington State Senators to oppose price-control and healthcare rationing legislation.
State ActionLetters to States Concerning 1332 Waivers
A similar letter, as written below, was sent to 12 states that are currently using a Sec.
State ActionOhio - Oppose HB 6
July 17, 2019 Ohio Statehouse 1 Capitol Square Columbus, Ohio 43215-4275 Dear Senator,
State ActionOklahoma Governor Stitt - Veto HB 2632
May 21, 2019 The Honorable Kevin Stitt Governor of Oklahoma Oklahoma State Capitol 2300 N Lincoln Blvd. Oklahoma City, Oklahoma 73105 Dear Governor,
